Subacute Thyroiditis: What to Do When NSAIDs Fail to Control Symptoms

Clinical Scenario

This protocol addresses patients with subacute thyroiditis in whom initial non-steroidal anti-inflammatory drug (NSAID) therapy has not achieved adequate control of inflammation or relief of anterior neck pain, and a next treatment step is required.

First-Line Treatment & Why It Was Not Enough

The first approach used was non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, targeting reduction of inflammation and relief of anterior neck pain in mild to moderate cases. When these goals are not reached — or symptoms persist beyond what NSAID therapy can manage — escalation to the next treatment line is indicated.

Next-Line Approach (Partial Overview)

When NSAIDs prove insufficient, a corticosteroid-based regimen is considered to achieve effective symptom relief. The full protocol specifies the structured approach for both adults and the pediatric population; those details are not outlined here.

Treatment Goal

✓ Remission with relief of symptoms.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3390/jcm14093233

However, NSAIDs alone may not suffice in the most severe cases.
Some authors point out that notwithstanding the use of NSAID, in some cases where symptoms persist, corticosteroids may be required for effective relief.
Prednisolone is generally recommended at a dose of 30 mg daily in adults, often achieving remission while minimizing side effects.
There is no recommendation for the pediatric population; past case reports typically used 1 to 2 mg/kg/day of prednisone or prednisolone.
Furthermore, they demonstrated that lower doses of prednisolone (20 mg daily, tapered over four weeks) could effectively relieve symptoms, highlighting the possibility of dose adjustment based on patient needs in adults (18 to 70 years old).

View source ↗